Sridhar, S., Harris, W., Tipgomut, C., Pan-Hammarström, Q., Salles, G., Herrera, A., Trneny, M., Morschhauser, F., Batlevi, C. L., Sugidono, M., Jiang, Y., Lenz, G., Jeyasekharan, A. D. (2025). A single-cell co-expression score of MYC and BCL2 identifies high-risk BCR-addicted DLBCL benefiting from polatuzumab vedotin in the POLARIX trial. Blood. https://doi.org/10.1182/blood-2025-3522